Assessing medical expenditure on 4 smoking-related diseases, 1996-2001

被引:11
作者
Kahende, Jennifer W.
Woollery, Trevor A.
Lee, Chung-won
机构
[1] Ctr Dis Control & Prevent, Natl Ctr Chron Dis Prevent & Hlth Promot, Off Smoking & Hlth, Atlanta, GA 30341 USA
[2] Ctr Dis Control & Prevent, Off Chief Sci, Off Publ Hlth Res, Atlanta, GA USA
[3] Ctr Dis Control & Prevent, Natl Ctr HIV STD & TB Prevent, Global AIDS Program, Atlanta, GA USA
关键词
smoking; lung cancer; chronic obstructive pulmonary disease; ischemic heart disease; cerebrovascular disease;
D O I
10.5993/AJHB.31.6.5
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 [公共卫生与预防医学]; 120402 [社会医学与卫生事业管理];
摘要
Objectives: To examine the current-period cost of treating 4 major smoking-related diseases: lung cancer, chronic obstructive pulmonary disease, ischemic heart disease, and cerebrovascular disease. Methods: Analyses are based on the MarketScan database, a medical claims database from large employers. Results: We found that total expenditures to treat ischemic heart disease were highest, followed by those to treat chronic obstructive pulmonary disease (COPD). When median expenditures per claim and disease severity were considered, lung cancer was the most expensive condition to treat and ischemic heart disease the least expensive. Median treatment expenditures increased as the severity of disease increased. Conclusion: Treating smoking-related diseases is costly in the current-period and over a lifetime.
引用
收藏
页码:602 / 611
页数:10
相关论文
共 10 条
[1]
Armour B. S., 2005, Morbidity and Mortality Weekly Report, V54, P625
[2]
Bartlett J. C., 1994, Morbidity and Mortality Weekly Report, V43, P469
[3]
*CDCP, 2002, MMWR-MORBID MORTAL W, V51, P642
[4]
Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P842
[5]
A NEW METHOD OF CLASSIFYING PROGNOSTIC CO-MORBIDITY IN LONGITUDINAL-STUDIES - DEVELOPMENT AND VALIDATION [J].
CHARLSON, ME ;
POMPEI, P ;
ALES, KL ;
MACKENZIE, CR .
JOURNAL OF CHRONIC DISEASES, 1987, 40 (05) :373-383
[6]
COX DR, 1972, J R STAT SOC B, V34, P187
[7]
CIGARETTE-SMOKING AND LIFETIME MEDICAL EXPENDITURES [J].
HODGSON, TA .
MILBANK QUARTERLY, 1992, 70 (01) :81-125
[8]
Miller LS, 1998, PUBLIC HEALTH REP, V113, P447
[9]
Smoking-attributable medical care costs in the USA [J].
Miller, VP ;
Ernst, C ;
Collin, F .
SOCIAL SCIENCE & MEDICINE, 1999, 48 (03) :375-391
[10]
OLIN GL, 2002, 5 MOST COSTLY MED DI